Peter R. Breggin MD
Psychiatric Drug Facts
 Peter Breggin, M.D.

 What your doctor may not know about:
 How psychiatric drugs really work
Adverse drug effects on the brain and mind
 The role of the FDA
 Drug company practices
 Recent medical and legal developments
 Electroshock and psychosurgery

Last updated May 3, 2008

      Peter  Breggin, M.D. began the full time private practice of psychiatry in 1968.  Dr. Peter Breggin has been informing the professions, media and the public about the potential dangers of drugs, electroshock, psychosurgery, involuntary treatment, and the biological theories of psychiatry for over three decades. Since 1964 Dr. Peter Breggin has been publishing peer-reviewed articles and medical books in his subspecialty of clinical psychopharmacology. He is the author of dozens of scientific articles and more than 20 professional books, many dealing with psychiatric medication, the FDA and drug approval process, the evaluation of clinical trials, and standards of care in psychiatry and related fields. 
     For thirty years Dr. Breggin has served as a medical expert in many civil and criminal suits including individual malpractice cases and product liability suits against the manufacturers of psychiatric drugs.  His work has provided the scientific basis for the original combined Prozac suits, for many tardive dyskinesia cases, and for label changes in many psychiatric drugs. 
      Dr. Breggin's background includes Harvard College, Case Western Reserve Medical School, a teaching fellowship at Harvard Medical School, a two-year staff appointment to the National Institute of Mental Health (NIMH), and a faculty appointment to the Johns Hopkins University Department of Counseling.
     In 1972 Dr. Peter Breggin founded The International Center for the Study of Psychiatry and Psychology (ICSPP) as a nonprofit research and educational network.  The Center is concerned with the impact of mental health theory and practices upon individual well-being, personal freedom, and family and community values.  He also founded the peer-review journal, Ethical Human Psychology and Psychiatry In 2002, Dr. Peter Breggin and his wife Ginger selected new and younger professionals to take over leadership of the journal and ICSPP (see ICSPP.org).


 

Brain-Disabling Treatments in Psychiatry:
Drugs, Electroshock and the Psychopharmaceutical Complex

by Peter R. Breggin, MD
Second Edition 2008, Springer Publishing Co., NY

The most comprehensive, up-to-date and detailed presentation of
Dr. Breggin’s concepts and scientific research
Including medication spellbinding
With new sections on
How to Withdraw from Psychiatric Drugs and Guidelines for Psychotherapy

Order your copy of Brain-Disabling Treatments in Psychiatry

 

COMPLETE INDEX


 Biography, Resume and Bibliography  of
Peter Breggin, M.D.

Selected Scientific Papers by Peter  Breggin, M.D.

Books by 
Peter  Breggin, M.D.
 


Read Dr. Peter Breggin's Latest Blog Posts
How to Contact 
Dr. Peter Breggin

SSRI - InducedViolence, Suicide& Abnormal Behavior 

NEW

Review of Stimulant Side Effects by Dr. Peter Breggin

 

NEW

Benzodiazepines:
Adverse Effects and Withdrawal
Neuroleptics
"Antipsychotic" drugs

 Prozac, Luvox, Paxil, Zoloft, Celexa Information

Ritalin Manufacturer Sued: Read Dr. Peter Breggin's Affidavits

Legal News

Brain-Disabling Treatments in Psychiatry

NEW

Tardive Dyskinesia
and Tardive Dementia caused by Neuroleptic Drugs

Eli Lilly Settles Zyprexa/Diabetes Cases for $690 Million (2005)

NEW

Legal News

Congress Investigates Ritalin & ADHD--Dr. Peter Breggin Testifies

Menninger Clinic Found Negligent by Jury After Patient Dies in Clinical Drug Trial 

Legal News

$1.6 Million Tardive Dyskinesia Verdict on October 14, 2005

NEW

Legal News

Glaxo Paxil Suit Resolved (2002)


Legal News

Schools Reporting Parents to Social Services when Family wants to Avoid Ritalin

$7.5 Million 
Awarded by Jury in Psychosurgery Case Against Cleveland Clinic
June 10, 2002

Legal News

<>$6.7 million Awarded by Jury in Risperdal Tardive Dyskinesia Case


Legal News
Judges Reduce Sentences
in Latest Paxil and Prozac Criminal Cases

Articles on Ritalin, Adderall, Other Stimulants, ADHD and Diagnosing Children

The New Lobotomists: Cingulotomy and Capsulotomy Resurge at Harvard and Brown Unviversities

Jury Awards $1.3 million
to Tardive Dyskinesia Victim--Appeals Judge Increases Award to $2 million citing Dr. Peter Breggin's testimony

Legal News

Paxil Withdrawal Suit Resolved


Legal News

Peter Breggin Calls for Moratorium on Psychiatric Drugs for Young Children

Shock Treatment --Its Brain-Damaging Effects

Legal News
Jury Awards $635,000 in Shock Suit

TD Case Settled After Peter Breggin Testimony

Legal News

Judge Discovers Secret
Prozac Settlement --Overturns Trial Verdict

Legal News

Psychiatry, Genetics and Racism--The Federal Violence Initiative

  Electroshock Regulations Proposed


Review of Electroshock Therapy by Dr. Breggin

Landmark Victory in First Canadian Tardive Dyskinesia Trial

Legal News

 Dr. Peter Breggin Analyzes the Eli Lilly Prozac-Induced Suicide and Violence Documents Now in Possession of the British Medical Journal (BMJ) A Case of Xanax and Prozac Mania Results in Reduced Sentence

1999 Peter Breggin Report to the JCAHO on Physical Restraints

Additional Legal Cases

Legal News

  Prozac: "Warning: this wonder drug could seriously damage your health"

Brief  for the Resolved Legal Paxil Withdrawal Suit


Legal News

Involuntary Intoxication by Psychiatric Drugs Sets Virginia Legal Precedent


Legal News

German Translations of Dr. Peter Breggin Articles
 

  The International Center for the Study of Psychiatry and Psychology - ICSPP

Subscribe to the journal:
Ethical Human Psychology and Psychiatry


Fenfluramine Damage to the Brain and Mind


 Ginger Breggin 
Web master 


 

Home - Books - Biography - Resume - Contact Dr. Peter Breggin

Peter Breggin, MD
101 East State Street, #112

Ithaca, New York 14850
By Appointment Only
Phone 607 272 5328
Fax 607 272 5329

Learn more about Ithaca, New York

WARNING!

When trying to withdraw from many psychiatric drugs, patients can develop serious and even life-threatening emotional and physical reactions. In short, it is dangerous not only to start taking psychiatric drugs but also can be hazardous to stop taking them. Therefore, withdrawal from psychiatric drugs should be done under clinical supervision. Principles of psychiatric medication withdrawal are discussed in Dr. Peter Breggin's book, Brain Disabling Treatments in Psychiatry: Drugs, Electroshock and the Psychopharaceutical Complex (Springer, NY, 2008).